|1.||Odumade, Oludare A: 1 article (04/2005)|
|2.||Frisancho-Kiss, Sylvia: 1 article (04/2005)|
|3.||Talor, Monica V: 1 article (04/2005)|
|4.||Njoku, Dolores B: 1 article (04/2005)|
|5.||Rose, Noel R: 1 article (04/2005)|
|6.||Fairweather, Delisa: 1 article (04/2005)|
04/01/2005 - "Anesthetics are believed to trigger hepatitis by covalently linking a trifluoroacetyl (TFA) chloride hapten to hepatic proteins, forming haptenated self-proteins. "
01/01/1997 - "Halothane causes an idiosyncratic hepatitis that is thought to result, in part, from immune reactions against one or more lumenal endoplasmic reticulum (ER) proteins that have been covalently modified by the trifluoroacetyl chloride metabolite of halothane. "
11/06/1998 - "Halothane hepatitis occurs because susceptible patients mount immune responses to trifluoroacetylated protein antigens, formed following cytochrome P450-mediated bioactivation of halothane to trifluoroacetyl chloride. "
10/01/1993 - "Most importantly, the vast majority of patients with a clinical diagnosis of halothane hepatitis have serum antibodies, which react with one or more specific liver microsomal proteins that have been covalently altered by the trifluoroacetyl chloride metabolite of halothane. "
|2.||Proteins (Proteins, Gene)
|6.||Anesthetics (Anesthetic Agents)